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ABSTRACT
1.10 phenanthroline linked to position 8 of E. coli transfer RNA^^® 
(tRNAP̂ ®) was used to study the interaction of tRNA with ribosomal 
RNA (rRNA). In the presence of Cû * and thiols the copper chelator
1.10 phenanthroline cleaves nucleic acids. When linked to position 
8 of tRNA*^® and bound to the hybrid peptidy1/exit site (P/E-site) 
or exit site (E-site) of the E. coli 70S ribosomes or 50S subunits 
the tRNA-phenanthroline (tRNA-OP) conjugate cleaves the 23S rRNA at 
nucleotide 2394. Data are also presented demonstrating that the 
tRNA-OP structure is equivalent to unmodified tRNA and that the 
tRNA-OP is not degrading during nucleolysis. These data prove 
that chemical nucleases can be used as powerful tools for the study 
of molecular interactions.
11
Acknowledgements.
For my mother, who always gave me water when I was thirsty
111
TABLE OF CONTENTS
ABSTRACT.......................................................... Ü
ACKNOWLEDGEMENTS................................................. i ü
LIST OF TABLES.....................................................Vi
LIST OF FIGURES.................................................. vii
ABBREVIATIONS................................................... viii
CHAPTER Introduction............................................... 1
1.0 Ribosome Structure and Function.. .................1
1.1.0 Ribosomal RNA Processing, Structure and 
Function.............................................1
1.1.1 Ribosomal RNA Processing....................... 1
1.1.2 Ribosomal RNA Secondary Structure............. 4
1.1.3 Ribosomal RNA Tertiary Structure.............. 5
1.2.0 Ribosomal Protein Structure and Function...........6
1.3.0 Ribosome Structure............................... 11
1.3.1 Small Subunit Structure and Function......... 13
1.3.2 Large Subunit Structure and Function......... 14
1.3.3 70S Ribosome Structure........................ 16
1.4.0 Translation.......................................17
1.4.1 Initiation....................................18
1.4.2 Elongation....................................18
1.4.3 Termination.................................. 19
1.5.0 Transfer RNA Processing, Structure and 
Function..........................................22
1.5.1 tRNA Processing.............................. 22
1.5.2 tRNA Structure............................... 22
1.5.3 tRNA Function................................ 23
1.6.0 tRNA-Ribosome Interaction........................ 25
1.6.1 tRNA Binding Sites............................ 25
1.6.2 Interaction of tRNA with rRNA................ 27
1.7.0 Techniques to study rRNA.......................... 29
1.7.1 Chemical Modification........................ 31
1.7.2 Chemical Crosslinking........................ 31
1.7.3 Mutagenesis.................................. 32
1.7.4 cDNA Probing................................. 32
1.7.5 Flourescent Energy Transfer...................33
1.8.0 Chemical Nucleases............................... 33
1.9.0 Proposed Problem................................. 36
CHAPTER 2 . 0 Materials and Methods..................................38
2.1 Ribosome Preparation..................................38
2 . 2 Oligodeoxynucleotide Synthesis and Purification......39
2.35' -end Labeling Nucleic Acids......................... 39
2.3.1 Dephosphorylation................................ 39
2.3.2 Phosphorylation...................................39
IV
2.4 Iodoacetal-1,10-phenanthroline Attachment to E. coli
tRNAf*®................................................ 40
2 • 5 Filter Binding Assay...................................41
2.6 In vitro Protein Synthesis............................ 41
2.7 Nucleolysis of rRNA by tRNA-OP........................ 42
2.8 Sequencing of rRNA.....................................42
CHAPTER 3.0 Results............................................... 44
3.1 Purification and testing of tRNA-OP...................44
3.2 Binding of tRNA and tRNA-OP........................... 45
3.3 Protein Synthesis of tRNA and tRNA-OP................ 48
3.4 Nucleolysis of rRNA with tRNA-OP on 70S Ribosomes. ...48
3.5 Nucleolysis of rRNA with tRNA-OP on 50S Subunits 48
3.6 Sequencing the 23S rRNA Cleavage Product............. 49
CHAPTER 4.0 Discussion............................................54
REFERENCES........................................................ 64
LIST OF TABLES
Table 1. Ribosomal Proteins & Functions.......................... 12
Table 2. Chemical Modification and Crosslinking of tRNA-rRNA
interactions............................................. 30
Table 3, Binding and protein synthesis of tRNA-OP and tRNA....... 50
VI
LIST OF FIGURES
Figure 1. Model of the 30S subunit 50S subunit and 70S ribosome 
adapted from electron microscopy....................... 3
Figure 2. Secondary structure map of the 16S rRNA from E. coli
........................................................ 7
Figure 3, 5* half of the secondary structure map of 23S rRNA
from E. coli............................................ 8
Figure 4. 3* half of the secondary structure map of 23S rRNA
from E. coli............................................ 9
Figure 5. Initiation of translation in E. coli..................20
Figure 6. Elongation in E. coli..................................21
Figure 7. Three dimensional structure of tRNA^^® from
S. cervesiae..........................................24
Figure 8. Allosteric and hybrid states models for the binding
of tRNA to the E. coli ribosome....................... 28
Figure 9. Chemical structure of lOP............................. 37
Figure 10. Affinity gel electrophoresis of tRNA**®-OP........... 46
Figure 11. Purification of tRNA-OP............................... 47
Figure 12. Nucleolysis of rRNA by tRNA-OP bound to 70S
ribosomes.............................................. 51
Figure 13. Nucleolysis of rRNA by tRNA-OP bound to 50S
subunits............................................... 52
Figure 14. Sequencing of the 23S rRNA cleavage product.......... 53
Figure 15. Portion of the 23S secondary structure map in the
area of the cleavage site............................. 60
Figure 16. Most probable orientation of the phenanthroline
group in the tRNA-OP molecule......................... 63
Vll
ABBREVIATIONS
a a tRNA........amino acyl transfer ribonucleic acid
ARM...........[ (N-Acryloylamino)phenyl]mercuric Chloride
ATP.......... adenosine triphosphate
A-site....... acceptor site of ribosome
cDNA..........complementary deoxyribonucleic acid
cpm...........counts per minute
DNA.......... deoxyribonucleic acid
DTT.......... dithiothreitol
E.coli....... Escherichia coli
EDTA..........ethylenediamine tetra-acetic acid
EF-G..........elongation factor G
EFTu..........elongation factor Tu
E-site....... exit site of ribosome
fMet-tRNA formyImethionine transfer ribonucleic acid
GDP.......... guanos ine diphosphate
GTP.......... guanos ine triphosphate
IF-1..........initiation factor 1
IF-2..........initiation factor 2
lF-3..........initiation factor 3
lOP.......... iodoacetal-1,10-phenanthroline
mol.......... mole
MPA.......... 3 -mercaptopropionic acid
mRNA......... messenger ribonucleic acid
pmol......... picomole
P-site....... peptidy 1 site of ribosome
RF-1......... release factor 1
RF-2......... release factor 2
RF-3......... release factor 3
RNA.......... ribonucleic acid
RRF.......... ribosome release factor
rRNA......... ribosomal ribonucleic acid
TC-70S....... tight couple 70S ribosomes
tRNA......... transfer ribonucleic acid
tRNA-OP...... transfer ribonucleic acid-phenanthroline molecule
Vlll
Introduction.
The cellular particle central to protein synthesis is the 
ribosome. The prokaryotic ribosome of Escherichia coli can be 
dissociated into 3 OS and 5 OS subunits. The 50S subunit 
contains 23S ribosomal RNA (rRNA) 2904 nucleotides in length, 
5S rRNA 120 nucleotidase in length, and 32 different proteins 
designated L1-L32. The 30S subunit contains 16S rRNA 1542 
nucleotides in length and 21 proteins designated S1-S21. 
(Figure 1) . Current interest in the ribosome has been spurred 
on by the discovery of catalytic RNA and it is now believed 
that rRNA plays an important role in protein synthesis.
1.0 Ribosome Structure and Function.
1.1.0 Ribosomal RNA Processing, Structure, and Function.
1.1.1 Ribosomal RNA Processing.
Although the primary structure of the rRNAs is extremely 
variable between organisms, there exist regions of primary 
sequence which are highly conserved phylogenetically. These 
sequences were the first to be extensively studied for their 
involvement in translation and are often implicated in the 
fundamental processes of the ribosome.
As stated above, the E, coli ribosome contains three 
different RNA molecules; the 23S rRNA and 5S rRNA found in the 
SOS subunit, and the 16S rRNA found in the 3OS subunit. The 
complete sequences of these RNAs were of the first ribosomal 
RNAs to be elucidated.
The processing of the prokaryotic RNAs involves the
action of multiple ribonuclease enzymes which specifically 
cleave the 165 and 235 pre-rRNA to form the mature rRNAs. Of 
those enzymes, ribonuclease III and ribonuclease M16 and M23 
are the most important. Ribonuclease III recognizes large 
stem structures formed by the flanking regions of the 165 and 
235 rRNA transcripts and produces specific cleavage sites 
along this stem. This leaves the mature 165 or 235 rRNA 
attached to a smaller stem structure which is then cleaved off 
by the action of either ribonuclease Ml6 or M23 respectively 
to form the mature rRNA.^
The processing of 55 rRNA involves three different 
ribonuclease enzymes, RNase III, RNAse E, and RNase MS. 
Ribonuclease III cleaves the 235 pre-rRNA in the flanking stem 
region as discussed above and thus releases the pre-5S rRNA 
for the action of RNase E. RNase E cleaves the 55 rRNA at 
specific sites leaving about three nucleotides on both the 3 * 
and 5* end. These nucleotides are the recognized and trimmed 
off of the mature 55 transcript by RNase MS
The list of sequenced rRNAs is continuing to grow and now 
there are several thousand rRNAs from both eukaryotes, and 
prokaryotes for which sequences are known. By comparing the 
sequences between organisms, it now appears that other than 
the highly conserved nucleotides, the primary sequence has 
little to do with the overall function of the ribosome, and 
that the overall structure of the rRNAs within the ribosome is 
what is conserved in evolution.
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Figure 1. Model of the 3OS subunit, 5OS subunit, 
and 70S ribosome adapted from electron 
microscopy.
1.1.2 Ribosomal rRNA Secondary Structure.
The secondary structure of rRNA is determined by base 
pairing of the primary sequence to form single-, double-, and 
triple- stranded structures. The secondary structures of the 
E,coll rRNAs are divided into functional domains designated I- 
III and 3* minor domain for the 16S rRNA, (Figure 2) and I-V 
for the 23S rRNA. (Figure 3-4). These domains contain both 
core, and variable regions. The core regions appear to have 
similar structures in all rRNAs, even though the primary 
sequences may be vastly different. Phylogenetic comparisons 
have been the most fruitful technique in determining the 
secondary structures of the rRNA molecules. By comparing the 
sequences of the rRNA over a broad range of organisms, a 
sequence conservation plot is constructed which displays 
secondary structure and suggests universally conserved 
sequences which may have functional roles.
By combining phylogenetic analysis with experimental 
probing, the secondary structure of the rRNA is further 
resolved. In this case, single or double-strand specific 
nucleases, chemical probes, or other nulceic acid modifiers 
are used to either digest or modify the rRNA. Because the 
modifiers are single-strand specific, double- stranded helices 
which are suggested by the phylogenetic analysis are immune to 
digestion or modification and the data can be used to support 
the phylogenetic findings. The secondary structures of the 
rRNAs from several organisms are now well characterized using
phylogenetic and experimental approaches.
1.1.3 Ribosomal rRNA Tertiary Structure.
The tertiary structure of the rRNA is formed by the 
folding of the secondary structure into a three dimensional 
structure through base pairing, hydrogen bonding, and coaxial 
stacking. These interactions are further stabilized by 
interactions with metal ions, and ribosomal proteins. Without 
crystallographic data the tertiary structure of large RNA 
molecules is very difficult to determine. Many of the 
nucleotides involved in tertiary structure are likely to be 
highly conserved and are difficult to find using a 
phylogenetic approach. Additionally, intra-rRNA nucleotide 
interactions are much less common than secondary base pairing, 
and the interactions between those bases are likely not 
constrained by classical Watson-Crick base pairing. In fact, 
in the smaller RNA molecules such as tRNA and several stable 
RNA hairpin structures in which the three dimensional 
structure has been deduced by NMR or crystallography, there 
are a plethora of bizarre intra-RNA interactions including 
Hoogsteen base pairing and bonding between the bases and the 
sugar phosphate backbone.̂  In large rRNAs there are probably 
many of these un-classical bonding patterns which makes 
solving the tertiary structure much more difficult.
Regardless of those difficulties, several research groups 
have begun modelling the tertiary folding of the E. coli 5S,
16S, and 23S using data from many different sources.*’ 
Modelling of the 16S rRNA has received the most attention due 
to the large amount of data already produced on this molecule, 
and the 3OS subunit. Basically the researchers constrain the 
structure of the 16S rRNA based on the secondary structure, 
the proximity to ribosomal proteins, interaction with 
ribosomal proteins, and RNA-RNA crosslinks. Using these 
constraints, the general path of the 165 rRNA is traced 
through the 305 subunit, and the general location of the 
major domains and helices are known. The efforts of these 
laboratories have yielded several models of the tertiary 
folding of the 165 rRNA, but the models are still very 
general, and far from an atomic picture of the actual 
structure.
1.2 Ribosomal Protein Structure and Function.
The E,coll ribosome contains 55 proteins. The 305 
subunit includes 21 proteins designated 51-521, and the 505 
subunit contains 34 proteins designated L1-L34. Except for 
four proteins, 51, 56, L7, and L12, all the ribosomal proteins 
are basic and range in size from 9000 to 35000 Da.^°
Initially, considerable effort in ribosomal research was 
devoted to the study of the r-proteins. This was largely due 
to the fact that the techniques for studying proteins at the 
time were far more advanced than the techniques to study 
nucleic acids. In addition, catalytic RNA had not been
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,Cĉ ioso
a ■ uc a- CU 
CA -  Û A U
t, ̂ aoc-a / , • A u UQACÔOOCCCOCACAA®. \' A
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Figure 2. Secondary structure map of the 
16S rRNA from E. coli.
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Figure 3. 5' half of the secondary
structure map of 23S rRNA from E, coli
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Figure 4. 3' half of the secondary
structure map of 23S rRNA from F, coli
discovered and it was therefore thought that the enzymatic 
activities of the ribosome must be carried out by the 
proteins. Since that time all of the primary sequences of the 
E. coli r-proteinsroughly half of the r-proteins in S, 
c e r v e s i a e and many of the rat-liver r-proteins^^ have been 
determined. Phylogenetic comparison between the E. coli 
sequences and eukaryotic r-protein sequences has revealed few 
statistically significant correlations. Only eight proteins 
of E. coli appear to be related to the eukaryotic r-proteins.
The secondary and tertiary structure of some of the 
ribosomal proteins has been worked on as well, but only two, 
L6, and L30, have been completely crystallized and the atomic 
structure determined. The structure of the C-terminal end 
of L7-L12 has also been determined through crystallography. 
In general, other than the sites of interaction with the rRNA 
the secondary and tertiary structures of the ribosomal 
proteins have not been very informative.
As stated above, with a few exceptions, the r-proteins 
which were once thought to the supply the enzymatic activities 
of the ribosome have not been found to have many important 
functional aspects in translation, other than creating the 
overall structure of the rRNA. Individual functions of some 
of the r-proteins have been found for only a handful of 
p r o t e i n s . ( T a b l e  1) . The lack of functional significance 
of the r-proteins, however, is also probably a reflection of 
a lack of study on their structures and functions, and they
10
are inherently difficult to isolate and characterize.
Although ribosomal research was initiated in the protein 
field, almost all of the study devoted to ribosomes today is 
now focused on the rRNAs. The present knowledge of the r- 
proteins is far from complete and needs much more in depth 
study to reveal what will most likely be many important 
functions.
1.3 Ribosome Structure.
Having the ribosomal RNA and ribosomal protein identities 
fairly well characterized has allowed ribosomal investigators 
to start modelling the ribosome. The ribosome has been 
visualized by electron microscopy and the locations of the 
ribosomal proteins within the ribosome structure have been 
well studied. Ribosomal proteins have been positioned 
relative to each other using several techniques. Digestion of 
the ribosomal subunits with nucleases yield ribonucleoprotein 
complexes containing several r-proteins. These complexes 
serve as protein neighborhoods to which data produced by 
chemical crosslinking can be compared.
Another technique used to position the r-proteins 
relative to each other is immune-electron microscopy.Using 
specific antibodies raised to the individual proteins, the 
localization of most of the E. coli ribosomal proteins on the 
subunit or ribosome has been directly visualized. In addition, 
the antibodies can be used in fluorescent energy transfer
11
Table 1. Ribosomal Proteins & Functions 
Small Subunit Proteins
SI: Interacts with Initiation Factor 3 (IF3) .
S4: Affects decoding of mRNA; may bind Release Factor 2
(RF2).
S5: Affects decoding of mRNA; may bind RF2.
S6: May interact with termination codons.
S7: May interact with mRNA.
SIO: May bind RF2.
S12: Affects decoding of mRNA; Interacts with streptomycin.
S18: May interact with termination codons.
521: Affects mRNA binding.
Large Subunit Proteins
LI: Affects tRNA binding in the Exit-site (E-site).
L2: May interact with termination codons; may be involved
with petidyl transfer.
L7/L12: May affect GTP hydrolysis rates; binds RF2; interacts 
with tRNA during elongation.
LIO: May interact with termination codons; affcts
elongation.
Lll: May bind RF2; affects thiostrepton binding.
L16: May be involved with peptidy1 transfer.
L27: May be involved with peptidy1 transfer.
12
studies to measure the distances between the proteins. But, 
the most accurate method in determining protein distances has 
been neutron scattering.^^ This technique uses reconstituted 
ribosomes in which two of the proteins isolated from E, coli 
grown in media containing deuterium. By analyzing the 
diffraction pattern of the ribosomes containing the deuterated 
proteins, the relative positions of the proteins to each other 
can be determined. The protein locations determined by 
neutron scattering have been the backbone of all the 3OS 
subunit model building to date. Combining the data produced 
by these techniques has produced models of the topography of 
the r-proteins in the ribosome.
1.3.1 Small Subunit Structure and Function.
As stated above the E, coli 3OS subunit contains a 16S 
rRNA species and 21 different proteins. Once fully assembled 
the subunit has the dimensions of approximately 
220Âx220Ax100Â.^^ From electron microscopic observation it 
appears that the 3OS subunit has distinct head, cleft and 
platform regions. As discussed above, several research groups 
have begun modeling the structure of the 3OS subunit using 
data obtained from a variety of sources. There are now 
several working models of the 3OS subunit which are constantly 
undergoing revision.®’
Within the 3OS subunit the most important structural area 
appears to be the decoding domain which has been located in
13
the cleft region as visualized by electron microscopy. This 
domain contains the last 140 nucleotides of the 3* end of the 
16S rRNA as well as proteins SI and S21. This region of the 
163 rRNA has been shown to interact both with the anticodon of 
tRNA, and with the mRNA through the Shine-Delgarno sequence. 
Proteins SI and S21 have also been implicated in IF-3 binding 
and interaction with the mRNA. It is now theorized that the 
path of the mRNA may be through the cleft of the 3OS subunit 
where the codon anti-codon interaction between the mRNA and 
the tRNA takes place. Again, as more data are added to the 
growing understanding of the ribosome, the models will be 
progressively more accurate.
1.3.2 Large Subunit Structure and Function.
The B. coli 50S subunit contains 34 proteins, 23S rRNA, 
and 5S rRNA. It has the overall dimensions of approximately 
250Âx25OÂxlS0Â.̂  Electron microscopy reveals three major
features of the subunit including the L7/L12 stalk, the LI 
ridge, and the central protuberance.̂  In addition, there now 
appears to exist a large tunnel through the center of the 503 
subunit, which may act as a channel for the nascent peptide 
chain to pass through during translation. The existence of 
this tunnel, however, is still debated. As with the 303 
subunit, the positions of the 503 r-proteins have been 
established relative to each other, and the folding of the 233 
and 53 within the subunit is starting to take shape. The
14
positioning of the proteins, however, has not been completed 
by neutron scattering, but through cross-linking and immune 
electron microscopy. Therefore, the 50S subunit r-protein 
positions are much less accurate and the working models of the 
5OS subunit are far behind the resolution of the 3OS subunit.
Within the 60S subunit, there appear to be three 
important structural domains; the GTPase domain, the 
elongation factor domain, and the peptidyltransferase domain. 
The GTPase domain is located in the stalk region of the 
subunit and is associated with nucleotides 1040 through 1100 
of the 23S rRNA and proteins Lll, and L7/L12. This region is 
important in binding Elongation Factor-G (EF-G) and is 
associated with the modulation of the rate of GTP hydrolysis. 
In addition the nucleotides in the vicinity of 1066 appear to 
be the site of action for the antibiotic thiostrepton, which 
acts by inhibiting the binding of EF-G.^
The other elongation factor domain is associated with 
nucleotides 2650 through 2680 of the 23S rRNA and proteins L3 
and L6. This region is placed approximately at the base of 
the stalk within the body of the 50S subunit. This domain is 
associated with the binding of elongation factor Tu (EF-Tu) 
and EF-G. Much study has been focused on this area since it 
is the site of action for the cytotoxins a-sarcin and ricin.
Perhaps the most important domain of the entire ribosome 
is the peptidyltransf erase domain. This domain is
associated with nucleotides around 2060, 2450, 2500, and 2600
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as well as proteins L2, L16, and L27. This domain is
approximately located at the base of the central protuberance 
within the body of the 50S subunit. Within this region lies 
the putative peptidyltransferase center (PT) where the amino- 
acyl bonds are formed during protein synthesis. There is 
growing evidence implicating this region as the catalytic core 
of the ribosome, including crosslinks between the rRNA and 5* 
end of tRNA,^° crosslinks between rRNA and the aminoacyl moiety 
of tRNA,^^ and crosslinks between the rRNA and the antibiotic 
puromycin^^ which acts by stopping the formation of the growing 
amino acid chain. This area of rRNA has probably received 
more attention in structure and function studies of ribosomes 
than any other, but the actual mechanism in which the peptide 
bonds are catalyzed by the ribosome is still a mystery.
1.3.3 70S Ribosome Structure.
When the 3OS and 50S subunits associate during initiation 
the 70S ribosome is formed. The E* coli 70S ribosome has the 
approximate dimensions of 170Âx230Âx250Â.^^ During association 
the 3OS and 50S subunits both undergo conformational changes 
and contact is made at a specific single region. Above this 
contact region there now appears to exist a large open area 
between the subunits in which the components of translation 
such as mRNA, and tRNA molecules can fit.* This area has been 
dubbed the interface canyon and is visible in high resolution 
electron micrographs. Researchers speculate that it is within
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this interface canyon that the work of the ribosome is 
performed. The path of the mRNA and tRNAs during decoding and 
peptide linkage is presumed to flow through the canyon and 
through the cleft of the 3OS subunit during which time the 
nascent peptide chain is shunted through the proposed tunnel 
in the 50S subunit to the cytosolic side of the ribosome. 
While these images may be very attractive and make common 
sense, there is little experimental evidence for the path of 
the translational components during protein synthesis, so most 
of these suggestions remain in the realm of theory.
It should be noted, however, that since the ribosome is a 
dynamic particle, the conformation of the rRNA and the 
proteins is certainly changing during protein synthesis, so 
many intermediate or transition structures exist. This 
statement also holds true for the tertiary structure and, to 
a lesser extent, the secondary structure.
1.4 Translation.
Translation involves the interaction of many cellular 
components with the ribosome. These include mRNA, tRNA,
initiation factors, elongation factors, release factors, GTP, 
and other many other molecules. The sites of interaction of 
these components with the ribosome have been investigated 
using a variety of techniques and the basic stages of protein 
synthesis have been described, which include initiation, 
elongation, and termination.
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1.4.1 Initiation.
Initiation begins by forming a complex between the 3OS 
subunit, initiation factor-1 (IF-1) and initiation factor-3 
(IF-3). (Figure 5) . At this point the mRNA is aligned on the 
ribosome, in part through an interaction between the Shine- 
Delgarno region of the mRNA and the anti-Shine-Delgarno region 
of the 16S rRNA, and by interactions with IF-1 and IF-3. A 
ternary complex of fMet-tRNA/1F-2/GTP then binds to the 3OS 
subunit releasing IF-3. Initiation is completed when the 60S 
subunit binds, IF-1 and IF-2 are released, and the GTP 
molecule is hydrolyzed. The initiation complex at this stage 
contains an interaction of the anticodon of the fMet-tRNA with 
the AUG start codon of the mRNA in the peptidyl-tRNA binding 
site (P-site) of the 70S ribosome. (Figure 5)
1.4.2 Elongation.
Elongation begins with the addition of a tRNA coding for 
the next codon. This step starts with the association of an 
elongation factor-Tu (EF-Tu)/GTP/aminoacy1-tRNA (aatRNA) 
complex with the ribosome. The tRNA is checked for fidelity 
by the ribosome, with non-cognate tRNA molecules being 
rejected, and the proper tRNA accepted with the release of EF- 
Tu/GDP. The ribosome now contains an initiator tRNA in the P- 
site, and an elongator tRNA in the acceptor tRNA site (A- 
site) . The amino group of the A-site amino acid is then 
presumably used in a nucleophilic attack on the carbonyl
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carbon of the P-site amino acid. The peptide bond is formed, 
with the subsequent movement of the deacylated tRNA from the 
P-site to the exit site (E-site) and the elongated peptide 
covalently attached to the tRNA which is translocated to the 
P-site.
This translocation of the mRNA and tRNA takes place with 
the interaction of elongation factor-G (EF-G) and the
hydrolysis of GTP. EF-G is then removed leaving the A-site 
empty and ready for another round of elongation. (Figure 6 ). 
The nascent peptide chain is terminated when a stop codon on
the mRNA is read. (Figure 6 )
1.4.3 Termination
Termination is performed by release factor-1 (RF-1) or 
release factor-2 (RF-2) depending on the termination codon and 
ends in the hydrolysis of the peptidyl-tRNA bond and the 
release of the peptide from the ribosome. The release of the 
nascent peptide chain from the ribosome involves the
interaction of EF-G and a ribosome release factor (RRF)
19
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1.5 Transfer RNA Processing, Structure and Function.
1.5.1 tRNA Processing.
Pre-tRNA transcripts from E, coli are formed either from 
single genes or from clusters of genes in the vicinity of both 
mRNA and rRNA transcripts. The mature tRNA is formed through 
the catalytic action of several ribonucleases. The pre-tRNA 
transcript is first cleaved by the action of RNase-III leaving 
a tRNA molecule with approximately 10-40 nucleotides on the 3* 
and 5* end of the tRNA molecule. RNAse-P then cleaves the 
transcript leaving a mature 5* end. The maturation of the 3* 
end of the tRNA transcript is not well understood but may 
include the activities of several ribonuclease enzymes 
including RNase-F, RNase-PH, and RNase-II among others. 
After complete maturation of the tRNA transcript many of the 
nucleotides of the molecule are post-transcriptionally 
modified by a plethora of enzymes and enzymatic steps. tRNA 
has perhaps the highest number of modified bases of any 
nucleic acid characterized, and more than 50 different post- 
transcriptionally modified bases have been found in the many 
tRNA molecules which have been fully charachterized.
1.5.2 tRNA Structure.
Prokaryotic tRNA molecules vary in length from 72 to 94 
nucleotides, but all have a common secondary and tertiary 
structure. In general all tRNAs have a stem, a D arm, an 
anticodon arm, a TYC loop, and a variable loop (V-loop).
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The most important aspects of this structure are the stem 
and the anticodon loop. The stem is usually consists of a 
helical structure formed by base pairing of the 5* and 3* 
sequences of the molecule. The 3* end of the stem always ends 
in CCA and it is the site of attachment for the amino acid. 
The anticodon arm consist of a short helical stem of 
approximately five base pairs and an open loop of up to seven 
nucleotides in which the anticodon is located. The nucleotide 
on the 5* side of the anticodon is always a uridine, and the 
5 * base of the anticodon is frequently modified, implying a 
role in its* wobble position.^*'^^
The tertiary structure of the tRNAs are governed by the 
same interactions as other RNA molecules, including hydrogen 
bonding, and coaxial stacking of the individual helices. As 
mentioned earlier, crystallographic analysis of tRNA has 
established many non-canonical base pairings within the 
molecule, including pairings between three base pairs, and 
hydrogen bonding to the sugar phosphate backbone. Through 
these bizarre tertiary interactions a common L-shaped feature 
of all the tRNAs is arrived at, and it is this overall 
structure which is important for the correct recognition of 
the tRNA by the corresponding amino-acyl synthetase enzymes, 
elongation factor-Tu, and the ribosome itself. (Figure 7).
1.5.3 tRNA Function.
The primary function of the tRNA molecule is to shuttle
23
Acceptor stem
T stem
54 76
T loop
3 ' Acceptor end
60
D loop
Variable loop
D stem
44
Anticodon stem
Anticodon
Anticodon loop
Figure 7. Three dimensional structure 
of tRNA from S. cerveslae.
24
the correct amino acid to the ribosome and present it in the 
correct conformation on the ribosome so that the peptide bond 
can be formed. The start of this function is the amino- 
acylation of the tRNA by its* corresponding synthetase enzyme. 
The aminoacylation of the tRNA molecule is a two-step process 
in wich the amino acid is first made into an aminoacyl 
adenylate with ATP and is then reacted with the tRNA to form 
an energy rich acyl bond with the 3 * hydroxyl of the terminal 
adenosine of the tRNA. The amino-acyl tRNA is then either 
complexed with IF-2 and GTP during initiation or EF-Tu and 
GTP during elongation.^^ This ternary complex then binds to 
either the P-site of the 3OS subunit during initiation, or the 
A-site of the 70S ribosome during elongation. At this point 
peptidyl transfer occurs, GTP is hydrolyzed and the factors 
are released. The tRNA molecule is then either degraded by 
nucleolytic enzymes, or recycled back into the system through 
the synthetase enzyme.
1.6 tRNA-Ribosome Interaction.
1.6.1 tRNA Binding Sites.
Initially it was proposed that the prokaryotic ribosome 
had only two sites for tRNA binding; the acceptor-site (A- 
site) , and the peptdyl-site (P-site) In the two site model, 
a round of peptide bond formation begins with an aminoacyl 
tRNA occupying the P-site of the ribosome, and the A-site 
being empty. The next tRNA molecule is then shuttled to the
25
ribosome by EF-Tu and is bound in the A-site followed by the 
hydrolysis of GTP. Peptide bond formation is then catalyzed 
by the ribosome, with the transfer of the growing peptide 
chain to the tRNA located in the A-site. This then causes the 
release of the deacylated tRNA from the P-site with the 
subsequent translocation of the tRNA with the growing peptide 
chain from the A-site to the empty P-site through the action 
of EF-G and GTP hydrolysis.
It is now accepted that the prokaryotic ribosome has an 
additional site for tRNA binding called the exit-site (E- 
site). There are currently two models which include the E- 
site in the binding of tRNA to the ribosome, the allosteric 
three-site model, and the hybrid states model.
The allosteric three site model is similar to the 
classical two site model, but it utilizes the E-site to bind 
deacylated tRNA after translocation and before it is released 
from the ribosome. In this model there are always two tRNA 
molecules present on the ribosome and both interact with mRNA 
codons. In addition, it asserts that there is a 
conformational change which occurs on the ribosome in which in 
the pre-translational state, the A-site and P-site have a high 
affinity for binding tRNA with the E-site in a low affinity 
state, or in the post-translational state, the P-site and E- 
site are in a high affinity state with the A-site in a low 
affinity state. In this model, when the A-site is filled, the 
E-site has a very low binding affinity for deacy 1-tRNA. After
26
translocation, however, the ribosome undergoes a 
conformational change and the A-site now assume a low affinity 
binding state with the E-site and P-site binding the 
deacylated and aminoacylated tRNAs respectively. (Figure 8 )
The hybrid states model asserts that during translation 
the tRNA molecules move through several hybrid binding sites 
on the ribosome. In this model, the 5OS subunit possesses 
the only site of interaction for deacylated tRNA in the E- 
site. An aminoacyl-tRNA is initially in the P/P site with the 
incoming tRNA occupying a hybrid A/entry site. Upon the 
hydrolysis of GTP and the release of EF-Tu, the two tRNA 
molecules then rachet to hybrid states consisting of a P/E 
site, and A/P site. After peptide bond formation, the release 
of EF-G, and GTP hydrolysis, the tRNA molecules rachet again 
to occupy the P/P site and the E-site. (Figure 8 )
1.6.2 Interaction of tRNA with rRNA.
Chemical modification has shown that a set of highly 
conserved bases in both 16s and 23s rRNA are protected when 
either tRNA, or a structural analog of the tRNA is bound. 
These sites have been the focus for cDNA binding experiments 
and site specific mutagenesis and several interactions have 
been substantiated. Perhaps the most convincing evidence for 
direct tRNA-rRNA interaction comes from crosslinking studies.
Using aryl azide groups attached to different areas of the 
tRNA molecule, crosslinks to both rRNA and
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ribosomal proteins are formed in situ. These crosslinks 
confirm a direct interaction between tRNA and rRNA at a 
resolution of 5-28Â corresponding to the distance between the 
azide and the tRNA.
From these studies it is clear that the different 
portions of the tRNA interact with rRNA during translation. 
The acceptor stem of the tRNA exclusively interacts with the 
23S rRNA in several different domains depending on the site of 
occupation on the ribosome. The anticodon loop exclusively 
interacts with the 16S rRNA within the decoding domain of the 
3 OS subunit. The sites of interaction as inferred by chemical 
modification and chemical crosslinking are summarized in 
Table 2.”
1.7 Techniques to study rRNA.
The size of the prokaryotic ribosome is problematic for 
the investigator interested in ribosomal structure and 
function. The ribosome is too small for thorough
investigation by electron microscopy yet too large for study 
by crystallography. In addition there are likely to be many 
conformations of the active ribosome during protein synthesis 
further complicating a molecular understanding of the 
structure. Because of these size limitations many creative 
and powerful techniques have been adapted for use in the study 
of ribosome structure.
It is apparent that the ribosomal RNA serves not only as
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Table 2. Crosslinking & Chemical Modification Between 
rRNA.
Crosslinking between tRNA.and rRNA.
tRNA: Position in tRNA: Crosslinked Nucleotide:
tRNA & 
rRNA
Species.
tRNA''*̂ ; 34 1400 165
tRNA"^: 32 956-986 165
tRNA““̂: 20 1302-1398 168
tRNAP**®; 37 1533-1543 165
tRNAP**®: 73 1945 235
tRNAP**®; 32 1338&1378 165
tRNAP**®: Amino Acid 2584&2451 235
tRNA”®*: 20 2281-2348 235
tRNA®®̂ : 46 2308 235
Chemical
Bindina
Modification
site:
Of rRNA by tRNA.
Modified Nucleotides: rRNA
Soecies.
A-site ; 529-531, 892, 1405, 1408, 1492-1498; 165
P-site : 532, 693, 794-795, 926, 966, ; 165
A-site
1338-1339, 1381, 1399-1401 
: 2254, 2439, 2451, 2553, 2555, 235
P-site
2602,
1916,
2609
1918, 1926, 2252-2253, 235
E-site
2439,
2585,
: 2 1 1 2 ,
2451, 2505-2506, 2584, 
2602
2116, 2169, 2394 235
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a structural determinant of the ribosome but also is pivotal 
in many of the functional aspects of protein synthesis and for 
this reason many of the techniques employed to study ribosomal 
structure and function are targeted to the rRNA. Chemical 
modification, mutagenesis, crosslinking, fluorescent energy 
transfer, and cDNA probing have all been successful to some 
degree.
1.7.1 Chemical Modification.
Chemical modification allows the researcher to determine 
the accessibility of each base in a large RNA molecule. 
Intermolecular and intramolecular interactions are seen as 
protections or enhancements to specific chemical probes which 
modify the N1 of purines or the N3 of pyrimidines and are 
detected by premature termination of reverse transcriptase 
using the modified rRNA as a template and synthetic DNA 
oligomers as primers. When ligands are bound to the ribosome 
the base modifications change and differences at individual 
bases are interpreted as either direct or indirect 
interactions between the ribosome and the bound ligand.
1.7.2 Chemical Crosslinking.
Crosslinking utilizes highly reactive chemical groups 
which, when exposed to U.V. light, form covalent bonds to
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nitrogens and carbons of both rRNA and ribosomal proteins. 
These reactive groups are linked to specific sites on 
molecules which interact with the ribosome. The molecules are 
then bound in situ on the ribosome and crosslinked. 
Intermolecular and intramolecular crosslinks are identified as 
migration differences in two dimensional electrophoresis and 
the exact location of the crosslink is determined through RNA 
sequencing.
1.7.3 Mutagenesis.
Site-specific mutagenesis of rRNA allows the researcher 
to change a single base in the rRNA molecule in order to 
determine its importance in the structure and function of the 
ribosome. Using a single stranded vector containing a 
portion of the rRNA gene, a mismatch oligonucleotide is 
hybridized and extended. The extension product is then cloned 
back into a plasmid vector containing the rRNA operon. When a 
suitable strain is transformed by the plasmid two thirds of 
the rRNA found in the cell contains the changed base, and the 
mutant ribosomes can be isolated and studied for changes in 
their structure and function.
1.7.4 CDNA Probing.
Complementary DNA (cDNA) probing involves binding a 
complementary DNA probe to single stranded regions of rRNA in
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order to perturb function. Single stranded regions of rRNA are 
the likely candidates for.function since they are conserved 
phylogenetically, and available for interaction. cDNA 
oligomers are radioactively labeled, bound to the ribosome, 
and then filtered through a nitrocellulose filter such that 
only radioactive probe bound to the ribosome is retained on 
the filter. Probing experiments can elucidate subtle 
intermolecular interactions as seen by an enhancement or 
decrease in probe or ligand binding to the ribosome or 
ribosomal subunit.
1.7.5 Flourescent Energy Transfer.
Fluorescent energy transfer measures the energy 
transferred between a donor fluorophore in an excited state to 
an acceptor fluorophore. The energy transfer is dependent on 
the distance between the donor and acceptor, the orientation 
of the fluorophores, and the overlap of the emission spectra. 
With careful controls molecular distances from 30-80Â can be 
measured.
1.8 Chemical Nucleases.
Although crosslinking studies are very convincing, the 
methodology is extremely complex and laborious. Many 
crosslinking reactions have very low yields and can be 
overlooked by difficult screening procedures. Recently
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researchers have discovered a class of metal chelators which 
can be used in the oxidative scission of nucleic acids 
These chemical nucleases, in the presence of a metal cation 
and a reducing agent, have a nucleolytic activity on both RNA 
and DNA. A useful metal chelator of this class is the 
molecule iodoacetal-1,10-phenanthroline (lOP). (Figure 9). 
lOP is a modified phenanthroline molecule containing a single 
reactive iodoacetal group which can be covalently linked to 
proteins or nucleic acids having a thio group.
Since their discovery, chemical nucleases have Been used 
in creative ways to investigate molecular structures and 
interactions. Sigman first used the nucleolytic activity of 
1,10 phenanthroline to investigate the conformation of the lac 
Operon.®* In that experiment 1,10 phenanthroline was used as 
a substitute for enzymatic nucleases to footprint the binding 
site of the coli RNA polymerase on the lac promoter. Use 
of 1,1 0 phenanthroline in this study resulted in an increase 
in resolution of the footprinting due to the smaller size of 
the phenanthroline molecule compared to the footprinting 
enzyme.
After it was discovered that 1,10 phenanthroline also 
cleaved RNA, Nierlich used it along with other footprinting 
chemicals to determine the lacZ ribosome binding site.® In 
this study it was determined that 1,10 phenanthroline was more 
evenly reactive and gave a higher resolution than the other 
chemical probes used.
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One of the most interesting studies using 1,10 
phenanthroline was done by Helene.^® Here the phenanthroline 
molecule was covalently attached to the 5* end of a DNA probe 
11 nucleotides in length which contained the sequence for a 
target site on Simian virus 40 DNA. Using this approach it 
was revealed that the phenanthroline-DNA probe conjugate 
formed a triple helix with the SV40 target DNA and cleaved it.
Another useful chemical cleavage reagent is Iron(II)- 
Ethylenediaminetetraacetic Acid (EDTA-Fe(II)). Like lOP, 
EDTA-Fe(II) can be covalently linked to nucleic acids and has 
been used in the double-strand or sequence specific scission 
of DNA and RNA. The reaction presumably occurs through an 
oxidative pathway when reducing agents such as dithiothreitol 
or sodium ascorbate are added.EDTA-Fe(II) was used by Cech 
to investigate the tertiary structure of the Tetrahymena 
ribozyme. In that study an EDTA-Fe(II) complex was tethered 
to guanosine 5'-phosphate and bound into the G-site of the 
ribozyme. Cleavage of the surrounding nucleic acid structure 
clarified the three dimensional structure of the catalytic 
core of the ribozyme.
More recently, Dervan used EDTA-Fe(II) to investigate the 
tertiary structure of tRNA****® by covalently attaching the 
molecule to position 47 and carrying out the auto-cleavage of 
the modified tRNA****®. The fragments of the cleaved tRNÂ **® fit 
closely with the known structure of the tRNA molecule.
Researchers are still unsure about the exact mechanism in
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which a phenanthroline-metal complex cleaves nucleic acids. 
It was first proposed that cleavage occurred through the 
release of an oxidative species generated by the reduction of 
the copper-phenanthroline complex by t h i o l s . M o r e  recently 
researchers have examined the possibility that the 
phenanthroline is cleaving the nucleic acids by an alkylation 
of the N-7 group of guanosine followed by depurination and 
elimination.^^ (Figure 9) . In either case the cleavage 
products occur on the opposite strand and are within 2-3 
nucleotides of the linked phenanthroline molecule.
1.9.0 Proposed Problem
The footprinting studies, and more importantly, the 
studies utilizing the nucleolytic activity of 1,10 
phenanthroline to investigate the SV40 triple helix and the 
three dimensional structure of the Tetrahymena ribozyme 
spurred us to use 1,10 phenanthroline in the study of the 
molecular interaction between tRNA and the ribosome.
Attaching lOP to a specific site on a tRNA molecule, 
binding the tRNA-phenanthroline conjugate (tRNA-OP) molecule 
to the ribosome in situ, and carrying out nucleolysis would 
allow the rapid and efficient screening of the entire rRNA 
molecule for intermolecular interaction with tRNA. I 
investigated this approach by covalently attaching the lOP 
molecule to the naturally occuring thio-uracil at position 
eight of E. coli tRNA'*'.
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2*0 Materials and Methods.
2.1 Ribosome and Ribosomal Subunit Preparation.
Cells from E. coli MRE600 were grown to mid log phase in 
trypticase soy broth at 37®C and then concentrated using a 
Millipore Pellicon Cassette system. After concentration the 
cells were pelleted in a Sorvall GSA rotor for five minutes at
5 . 0 0 0 rpm, and the pooled pellets were then ground with 
alumina in a mortar and pestle in cracking buffer (lOmM Tris- 
HCl pH 7.4, 15mM MgClj, ISOmM KCl) for 45 minutes at 4®C. The 
suspension was centrifuged briefly to remove the alumina and 
un-lysed cells. The alumina fraction was then washed with 
buffer, re-centrifuged, and the supernatants pooled. The 
supernatants were then centrifuged at 50,000 x g for one hour, 
the pellets discarded, and the supernatant centrifuged at
250.000 X g for three hours. The pellets were resuspended in 
wash buffer (lOmM Tris-HCl pH 7.4, 15mM MgClj, 0.5M NH4CI) and 
centrifuged at 50,000 x g for one hour and 250,000 x g for 
three hours. The crude ribosomal pellets were then 
resuspended in tight-couple 70S buffer (lOmM Tris-HCl pH 7.4, 
6mM MgCl2, lOOmM KCl) to produce tight couple 70S ribosomes or 
in 30-50 buffer (lOmM Tris-HCl pH 7.4, 1.5mM MgClj, lOOmM KCl) 
to produce 50S and 3 OS subunits. The resuspended crude 
ribosomal fractions were then pooled and purified using zonal 
centrifugation through a 10-38% sucrose gradient in a Beckman 
Til4 rotor. The appropriate fractions determined by Aĵ o 
readings were pooled and pelleted and then dialyzed against
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-500 volumes of either tc70 or 30-50 buffer for 12-15 hours. 
Ribosomes or ribosomal subunits were then divided into small 
aliquots and stored at -70®C.^^
2.2 Oligodeoxynucleotide synthesis and purification.
DNA oligomers were synthesized on a Biosearch 8600 DNA 
synthesizer using standard phosphoramidite chemistry. The 
oligomers were removed from the support column by incubating 
the contents in concentrated NH4OH at 55®C for 12 hours. The 
crude oligomer mixture was then purified using NENprep nucleic 
acid purification cartridges (DuPont) according to 
manufacturers * instructions
2.3 5 '-end Labeling of Nucleic Acids.
2.3.1 Dephosphorylation of Transfer RNA.
Approximately 100 picomoles (pmol) of E. coli tRNAP**® was 
resuspended in lOOmM Tris-HCl pH 8.0 and incubated with 1 
units of RNase free alkaline phosphatase for one hour at 50°C. 
The reaction was then extracted three times with equilibrated 
phenol, ethanol precipitated, and resuspended in PKBM buffer 
(50mM Tris-HCl pH 7.6, lOmM MgClz, 3mM DTT, O.lmM EDTA)
2.3.2 Phosphorylation.
To approximately SOpmol of DNA oligomer or SOpmol of 
dephosphorylated tRNA, 10/Ltl of ATP'yP̂  ̂ (3000 Ci/mMol) and 2 
units of T4 polynucleotide kinase were added in PKBM buffer.
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The reaction was incubated at 37®C for 30 minutes. The 
product was then purified using NENsorb 20 columns (DuPont) 
according to manufacturers* instructions. The purified 
fractions were pooled, dried, and resuspended in TE buffer 
(lOmM Tris-HCl pH 7.5, ImM EDTA).^
2.4 Iodoacetal-1,10-phenanthroline Attachment to E. coll 
tRNA*****.
Two A260 units of E. coli tRNA*’*' were dissolved in 35mM 
TEA-OAc pH 7.6, 3. 8M acetonitrile, 0.ImM DTT, and 4,25mM
iodoacetal-1,10-phenanthroline (a kind gift from Dr. David 
Sigman, UCLA) in DMSO, and allowed to incubate at 25®C for 12 
hours in the dark.*’ Following the attachment, the tRNA-OP 
product was precipitated out of the reaction with three 
volumes of ethanol and resuspended in 15 fil of tracking dye 
(0.02% bromophenol blue, 0.02% xylene cyanol, 7M urea). The 
sample was then loaded on a 20% polyacrylamide gel containing 
7M urea (dPAGE) in TBE buffer (89mM Tris-borate pH 8.3, ImM 
EDTA) and run at 40 mA for one hour. Following 
electrophoresis the products were visualized using U.V. 
shadowing and the slowest moving band was cut from the gel and 
isolated using electro-elution in TE buffer containing 3M Na- 
OAc in the annode buffer. The elution was run at 5mA for one 
hour. The isolated product was then ethanol precipitated and 
resuspended in TE buffer to a concentration of approximately 
lOpmol/Ml as determined by A260 readings. To quantify the
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attachment of the phenanthroline molecule to tRNA the isolated 
product was loaded on a 20% dPAGE affinity gel containing 10 
/ig/ml of [ (N-Acryloyamino)phenyl] mercuric chloride (APM) , and 
visualized by staining with 0 .2 % methylene blue.^’**®
2.5 Filter Binding Assay.
A mixture of 5 *-end labeled and unlabeled tRNA or tRNA-OP 
having a specific activity of 500 cpm per picomole was bound 
to un-programmed 70S ribosomes at a 1:1 ratio in binding 
buffer (6mM MgClj, lOmM Tris-HCl pH 7.5, lOOmM KCl) . The 
reaction was incubated at 37°C for 30 minutes and then at 4®C 
for 3-5 hours at which time the reaction was diluted to 1ml in 
binding buffer and filtered through a 0.45)um nitrocellulose 
filter. After repeated buffer washes the radioactivity 
retained on the filter was counted using liquid 
scintillation.*^
2.6 In vitro Protein Synthesis.
A solution containing 17mM Tris-HCl pH 7.4, 17mM Mg-OAc, 
68mM NH4CI2, 3mM ATP, 3mM GTP, 8mM BME, 3mM DTT, 17mM PEP, and 
0.00ImM tRNA or tRNA-OP was added to a mixture containing 
pyruvate kinase, sl50 fraction, phenylalanine, and tc70S 
ribosomes. The reaction was incubated for 10 minutes at 37®C 
at which time poly U was added as message. The reaction was 
then incubated at 37®C for 3 0 minutes, stopped with 1ml of ice 
cold 5% TCA, heated to 90®C for 5 minutes and filtered through
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a GC filter. Following several washes with ice cold TCA, the 
filters were dried and the retained radioactivity was counted 
using liquid scintillation.*^
2.7 Nucleolysis of rRNA by tRNA-OP.
tRNA-OP was bound to un-programmed 70S ribosomes at a 1:1 
ratio in binding buffer at 37®C for 30 minutes. At the end of 
the 30 minute incubation 1000 pmol of CUSO4 and 1000 pmol of 
MPA was added to induce nucleolysis.®^ The reaction was 
incubated an additional 3-5 hours at 4®C at which time the 
rRNA was extracted 3 times with an equal volume of phenol, and 
ethanol precipitated. The rRNA pellet was then resuspended in 
15/11 of tracking dye, run on a 5% polyacrylamide-7M urea gel, 
and visualized by staining with 0 .2% methylene blue.
2.8 Sequencing of rRNA.
Ribosomal RNA fragments were visualized using U.V. 
shadowing, cut from the gel, eluted, and ethanol precipitated 
as described above. Approximately one microgram of the eluted 
fragment was annealed to a 5 * end labeled primer complementary 
to a rRNA region 3 5 nucleotides on the 3* side of the rRNA 
fragment in annealing buffer (50mM Tris-HCl pH 8.0, 20mM 
MgClg, lOOmM KCl). The annealing reaction was heated to 80®C 
for 3 minutes, quenched on ice, and then divided into four 
parts for addition to each dideoxy extension mix. Typically 
2 .5/1I of the annealing reaction was added to 3.0/il of the
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dideoxy dilution (0.25mM ddA, 0.25mM ddC, 1.25mM ddG, 1.25mM 
ddT) , and 5.0^1 of extension mix (0.2mM dATP, 0.2mM dCTP, 
0.2mM dGTP, 0.2mM dTTP, 50mM Tris-HCl pH 8.0, 125mM KCl, 25mM 
MgClj, lOmM DTT, 0.2 units AMV reverse transcriptase). The 
extension reaction was incubated at 37®C for 45 minutes at 
which time 6/xl of stop solution (98% formamide, 0.02% xylene 
cyanol) was added. The reactions were boiled for 3 minutes 
and loaded on a 0.4mm 14% polyacrylamide-7M urea gel.
Electrophoreses was for 3-4 hours at 70 watts constant power 
and following electrophoresis the gel was visualized using 
autoradiography.
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3.0 Results
3.1 Purification and Testing for Self Cleavage of the tRNA-OP 
Molecule.
After attachment of the IGF to the Ê . coli tHNA****® the 
modifeid tRNA-OP molecule was purified by gel-electroelution. 
The tRNA-OP band was eluted from the gel slice using TE buffer 
containing 3M Na-OAc in the annode buffer. Yeilds varied from 
50-70%.
In order to quantify the attachment of the phenanthroline 
molecule to E. coli tRNAP**®, affinity gel electrophoresis was 
used. Figure 10 shows the results of running tRNA*̂ '̂ ®-OP and 
unmodified tRNA***** on a 20% dPAGE gel containing 10 /ig/ml of 
APM. Under these conditions there is a substantial migration 
difference between the unmodified tRNA****® and the tRNAP'*®-OP 
molecules due to the affinity of APM for uncomplexed thio 
groups.
Denaturing polyacrylamide gel electrophoresis was also 
used to test the purity of the final tRNA-OP product, as well 
as to see if the tRNA-OP molecule was being degraded during 
the nucleolysis reaction. Figure 11 shows the purified 
tRNA^^^-OP product run next to unmodified tRNA****®. Under the 
electrophoresis conditions used, a slight migration difference 
and a broadening of the product band could be resolved from 
the unmodified starting material. Figure 8 also shows the 
reaction product after the purified tRNA-OP was incubated with 
CUSO4, and 3-mercaptopropionic acid (MPA) used to induce
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nucleolysis. No difference between the purified tRNA-OP and 
the reacted tRNA-OP could be observed indicating that the 
tRNA-OP molecule was not being degraded during nucleolysis.
3.2 Binding of tRNA***-OP and tRNA**%
The binding of tRNA or tRNA-OP to active, salt washed 
tc70S ribosomes was assayed using nitrocellulose filtration. 
Under the filtration conditions used as described in chapter 
2, ribosomes are retained along with any tRNA or tRNA-OP bound 
to the ribosome, while unbound tRNA or tRNA-OP is not 
retained. The percent binding of the tRNA or tRNA-OP is then 
calculated as the molar ratio of the tRNA or tRNA-OP retained 
on the nitrocellulose to the ribosomes. Table 3 details the 
binding of tRNA or tRNA-OP. tRNA or tRNA-OP was bound to the 
ribosome at a 1:1 ratio without message to duplicate the same 
conditions as the nucleolysis reactions. Under these 
conditions the binding of the tRNA and the tRNA-OP were nearly 
equivalent. Competition for binding between tRNA and tRNA-OP 
was also investigated by first binding unmodified tRNA to the 
ribosome and then carrying out the binding of labeled tRNA-OP 
as described. Under the conditions used the tRNA or tRNA-OP 
is binding in either the E and/or P/E-site so the binding 
represents the cumulative amount of binding in the two sites. 
Competition did not significantly decrease the binding of the 
tRNA-OP.
45
Figure 10. Affinity gel electrophoresis of 
purified tRNA-OP. 200 pmol of either 
yeasttRNAP*“, ^  coli tRNAP*“, or tRNA-OP were 
loaded on a 20% dPAGE containing 10 /ig/ml APM 
and run for 2 hours at 20mA. Lane 1: yeast 
tRNA***“' Lane 2: Crude coli tRNA'’*'®.
Lane 3: Purified tRNA-OP.
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Figure 11. Purification of tRNA-OP. 200 pmol 
of either coli tRNÂ **®, tRNA-OP, or tRNA-OP 
incubated with CUSO4 and MPA were loaded on a 
20% dPAGE and run for 2 hours at 20mA. Lane 1: 
Crude tRNÂ **®. Lane 2: Purified tRNA-OP. Lane 
3: Purified tRNA-OP incubated CUSO4 and MPA.
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3.3 Protein synthesis using tRNA or tRNA-OP.
The ability of tRNA-OP or tRNA to carry out in vitro 
protein synthesis was also investigated. Table 3 describes 
the levels of incorporated Phe when either tRNÂ **® or tRNA****®- 
OP was used as the source of tRNA in the poly-uracil directed 
synthesis of poly-Phe. As with the binding data, the level of 
protein synthesis between the modified and unmodified tRNA 
molecules was nearly equivalent.
3.4 Nucleolysis of rRNA by tRNA-OP bound to 70S ribosomes.
Figure 12 shows the rRNA extracted after nucleolysis with 
tRNA-OP. After the nucleolysis reaction as described in 
chapter 2, a fragment of rRNA migrating with a size of -520 
bases, as estimated by RNA size markers, was produced. The 
fragment was reproducible over a range of magnesium 
concentrations from lOmM to 25mM MgClj indicating that the 
fragment was being produced when the tRNA-OP was bound in the 
E-site or P/E-site of the 70S ribosome. In addition, a 
competition between pre-bound unmodified tRNA and tRNA-OP 
attenuated the cleavage product. No apparent cleavage occurs 
in the control where lOP is in solution.
3.5 Nucleolysis of 238 rRNA by tRNA-OP bound to SOS subunits.
In order to determine whether the rRNA fragment produced 
by tRNA-OP was originating from the 23S or the 16S rRNA, 
nucleolysis experiments were performed on 3OS and 50S
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subunits- Only the 23S rRNA of the 50S subunit was cleaved by 
tRNA-OP. No cleavage occurred on the 16S rRNA in the 3OS 
subunits programmed with poly U. (Figure 13) The cleavage 
product produced was the same size as the rRNA fragment 
generated on 70S ribosomes, and occurred consistently over a 
range of magnesium concentrations from lOmM to 25mM. This 
again indicates that fragment was produced by a tRNA-OP 
molecule bound in the P/E-site or E-site of the 50S subunit.
3.6 sequencing the 238 rRNA Cleavage Product.
In order to determine the exact location of the site of 
scission, RNA sequencing was employed. Figure 14 shows the
sequence of the 5* end of the rRNA fragment. Under the
sequencing conditions a labeled primer complementary to a 
region -35 nucleotides on the 3* side of the cleavage site was 
extended. The 5 * sequence is read at the top where the
reverse transcriptase fell off the template. The sequence 
indicates that cleavage was occurring on the 3 * side of
nucleotide 2394 of 23S rRNA.
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Table 3. Binding and protein synthesis of tRNA-OP and tRNA.
Filter binding assay tRNA and tRNA-OP were 5 *-end 
labeled using ATP^P^^ and polynucleotidyl transferase. A 
mixture of labeled and unlabeled tRNA or tRNA-OP having a 
specific activity of 500 cpm per picomole was bound to TC70S 
ribosomes at a 1:1 ratio.
In vitro protein synthesis Levels of acid precipitable 
poly-Phe. synthesized in an in vitro protein synthesis 
reaction using either unmodified tRNA”*® or tRNA-OP”*® in the 
reaction as described in the materials and methods.
Binding:
E.coli tRNAP**®: 19.8%±2.5% 
tRNA-OP: 22.5%±3.0% 
tRNA-OP Competition: 17.3%Jl5.5%
Protein Synthesis:
tRNA""': 27691.5±1257.5 cpm C" Phe. 
Incorporated.
tRNA-OP: 28760.0±826 cpm C“ Phe. 
Incorporated.
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Figure 12- Nucleolysis of rRNA by tRNA-OP bound to 70S 
ribosomes.
Lane 1: rRNA extracted from 70S ribosomes. Lane2: Control 
reaction in which all the components of the reaction are 
present except that the 1,10 phenanthroline was not linked to 
the tRNA and was free in solution. Lane 3: Nucleolysis
reaction as described in chapter 2. Lane 4 : Competition in 
which native tRNA was first bound to the ribosome at a 1:1 
ratio before the tRNA-OP was added and nucleolysis was 
started. Numbers indicate the size, in nucleotides, of RNA 
size markers. (BRL)
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II
Figure 13. Nucleolysis of rRNA by tRNA-OP bound to 50S 
subunits.
Lane 1: rRNA extracted from 3OS subunits. Lane 2:
Control reaction on 30S subunits as described for figure 9. 
Lane 3: Nucleolysis reaction on 3OS subunits as described in 
chapter 2. Lane 4: rRNA extracted from 60S subunits. Lane 5: 
Control reaction as described for figure 9. Lane 6: 
Nucleolysis reaction as described in chapter 2. Lane 7: 
Competition experiment as described in figure 9. Numbers 
indicate the size, in nucleotides, of RNA size markers. (BRL)
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Figure 14. Sequence analysis of the 23S rRNA cleavage 
product. The rRNA cleavage product was visualized using U.V. 
shadowing and cut from the gel, eluted, and ethanol 
precipitated. The sequencing reactions were run as described 
in the materials and methods. The sequence is read from 
bottom to top, the uppermost bands corresponding to where the 
AMV reverse transcriptase fell off the template at the 5' end 
of the cleavage product.
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4.0 Discussion
The experiments presented here and other recent work have 
proven the usefulness of chemical nucleases for the study of 
molecular interactions. This study was initiated to determine 
if chemical nucleases could be used as a potential tool for 
the study of molecular interactions in translation. Using the 
chemical nuclease 1,10-phenanthroline attached to the thio-U 
at position 8 of Ej_ coli tRNAP**®, cleavage occurred at 
nucleotide 2394 of 23S rRNA when the tRNA is bound in the P/E- 
site or E-site.
As noted in chapter one, throughout the history of 
ribosomal research investigators have struggled with the 
placement of tRNA on the ribosomal subunits, and the ribosome. 
The two site model of tRNA binding was eventually replaced by 
the three site model, and now there is evidence for yet 
another site. A plethora of inventive molecular techniques 
have been developed to map the positions of the tRNA molecules 
on the ribosome during various stages of protein synthesis.
Attachment of phenanthroline to the tRNA molecule was 
determined through affinity gel electrophoresis. (Figure 10) . 
Similar molecules have been attached to tRNA at the thio- 
uracil position using the same flouro-acetal chemistry and 
have been quantified at 80-95% attachment, and that is 
approximately the same level of attachment we see with the lOP 
molecule.
From previous studies, in which crosslinking agents were
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attached to this site in tRNA,^^ it seemed that attaching the 
phenanthroline molecule to the thio-uracil position of tRNA 
should not affect the function of the tRNA in a translating 
system. Our results support those reults also. Table 3 shows 
the binding of end labeled tRNA-OP was performed to
determine the integrity of the molecule compared to unmodified 
tRNA. Within the error limits the binding of the modified and 
unmodified tRNA were equivalent.
A competative binding experiment was then carried out in 
which un-labeled, unmodified tRNA was used to inhibit the 
binding of the tRNA-OP by competing for the same ribosomal 
binding site as the tRNA-OP. Under the binding conditions 
used, no competition was observed within the range of error. 
The lack of competition has two possibilities. First the 
modified tRNA could be binding non-specifically to the 
ribosome. However, evidence against this is provided by the 
In vitro protein synthesis data, and by the consistency and 
homogeneity of the cleavage product produced by the tRNA-OP. 
The second possibility is that the modified tRNA may have a 
slightly higher binding constant. This could be resolved by 
performing a series of binding experiments with both modified 
and unmodified tRNA and determining the binding constants of 
the molecules to the ribosome. If the k, of the tRNA-OP was 
higher than that of the native tRNA and exchange was 
occurring, then competition would not be seen.
Within the range of error the level of protein synthesis
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by either the tRNA or tRNA-OP was equivalent. This suggests 
that the tRNA-OP is being recognized and aminoacylated by the 
translational apparatus which is the most stringent test for 
integrity of the modified molecule.
The cleavage of 23S rRNA by the tRNA-OP molecule bound In 
situ on the 70S ribosome or 50S subunit was very reproducible. 
The cleavage product was constant over a range of Mg^^ from 
lOmM to 25mM. Under the higher magnesium concentrations, and 
in the absence of message, the tRNA is putatively bound in the 
P/E-site of the ribosome. The exact site of cleavage was 
located at nucleotide 2394, as determined by RNA sequencing of 
the cleavage product. This result indicates that the thio- 
uracil at position 8 of E. coli tRNAP**® is within 15Â of 
nucleotide 2394 of 23S rRNA when the tRNA is bound in the P/E- 
site or E-site. (Figure 15)
Chemical modification has located a conserved set of 
nucleotides in both 16S and 23S rRNA which appear to be 
involved in tRNA binding. Wagner was one of the first 
researchers to demonstrate a rRNA-tRNA interaction using this 
technique, demonstrating an interaction between the 1400 
region of the 16S and tRNA.^ This study was later expanded by 
Noller establishing several new 165 rRNA-tRNA interactions as 
well as several 235 rRNA-tRNA interactions with the tRNA bound 
in the A, P, and E-sites. These interactions were primarily 
located in domain V of the 235 rRNA in or near the loop 
putatively involved with peptidyl transfer
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Included in these sites is base C-2394 which displayed a 
protection from the chemical modification by the tRNA molecule 
bound to the E-site. Although our reaction conditions with 
high magnesium (25mM) or with the addition of poly-U should 
bind tRNA exclusively in the P/E-site of the ribosome we have 
demonstrated that cleavage occurred at the same nucleotide, C- 
2394. This is reasonalble since the E-site interaction in 
this hybrid state occurs on the 5OS subunit.
Noller has produced a model of tRNA binding to the 
ribosome which involves several intermediate states in 
translocation. In this model the tRNA molecule moves through 
a series of hybrid sites including the peptidyl/exit-site 
(P/E-site) and the aminoacyl/peptidyl-site (A/P-site). At 
lOmM magnesium the deaclyated tRNA-OP should be bound in the 
E site, but at 25mM magnesium or with the addition of poly-U 
the tRNA-OP should be bound exclusively to the P/E-site. In 
our experiments we observed hydrolysis of nucleotide C-2394 
under both of these conditions. This suggests that position 
8 of tRNA does not move more than 15Â during the translocation 
of the tRNA from the P/E-site to the E-site. Another 
possibility is that nucleotide 2394 is located in a dynamic 
region of the rRNA which may either move, or act as a fulcrum 
for the translocation event. In either case, whether the tRNA 
is in the P/E-site or in the E-site, the 3*-CCA end of the 
tRNA is presumably interacting with a set of defined 
nucleotides of the 23S rRNA which form part of the E-site on
57
the 50S subunit.
Chemical crosslinking of tRNA to the ribosome has been 
the most important technique demonstrating the interaction of 
selected rRNA sequences in the binding of tRNA. Several 
researchers have used a variety of crosslinking reagents 
linked to the anticodon of tRNA to crosslink 16S rRNA at 
positions C-1400, 956-986, and 1533-1543.
Chemical crosslinkers have also been attached to other 
areas of the tRNA molecule and cross linked to 23S rRNA. Barta 
used a loA crosslinking reagent attached to the 3*-end of the 
tRNA molecule to crosslink to nucleotides U-2584 and U-2585 
when tRNA was bound in the A-site.** The study was later 
expanded and two new nucleotides, A-2503 and U-2506, were 
crosslinked to the tRNA bound in both the P-site and A-site.
With greater relation to our study, crosslinking 
reagents have been attached to the dihydrouridine loop (D- 
loop) and the variable loop (V-loop) of the tRNA molecule and 
cross linked to 23 S rRNA. Podkowinski used an 18Â cross linker 
attached to the D-loop to crosslink nucleotides A-2281 and A- 
2358 in 23S rRNA. In a separate study Mitchell crosslinked 
the variable loop of tRNA bound in the P-site to nucleotide A- 
2309 of 23S rRNA.^°
Although nucleotide C-2394 was not directly crosslinked 
in any of these studies, there is good agreement of these 
results with our data. For instance, if the tertiary 
structural interaction between the nucleotides 2328-2330 (A-U-
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G) with nucleotides 2385-2387 (U-A-C) holds true,^’ then the 
stem loop containing nucleotide 2309 would be placed proximal 
to the region containing nucleotide 2394. When the tRNA is 
bound in the P-site it would allow position 8 of the tRNA to 
be located near nucleotide 2394 concurrently with the D-loop 
near nucleotide 2358 and the V-loop near nucleotide 2309. 
Chemical crosslinking studies in which the crosslinking 
reagent was attached to the same position on tRNA****® have not 
implicated nucleotide 2394 directly. However, in all of these 
studies the crosslinking reagent has been tethered to a long 
carbon linker of approximately 25-30Â. This distance is 
between two to three times the length of the phenanthroline 
linkage and may account for the difference in the results.
From these results it appears that this region of the 
rRNA cradles the body of the tRNA and positions the CCA end in 
the proposed peptidyl transfer site. When two or more tRNA 
molecules are bound on the ribosome concurrently they must be 
positioned close together at both the CCA 3'-terminus and the 
anticodons. There are currently two configurations proposed 
which would allow for these close contacts between the 
neighboring tRNA molecules. The R-configuration^ positions 
the planes of the two tRNA molecules at 90® relative to 
eachother, and the S-configuration postions the planes of the 
tRNAs at 270®.w
Our results cannot be used to argue in favor of one 
configuration over the other. Since the tRNA is not degraded
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Figure 15. A portion of the 23S secondary structure map
in the area of the cleavage site. PT: Indicates proposed 
peptidyl transfer region. Cleavage is marked with an 
arrow.
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by the nucleolytic activity of the attached phenanthroline, it 
is probable that the phenanthroline molecule is projecting out 
from position 8 towards the 3'-terminus.(Figure 16). If, in 
fact, that is the location of the phenanthroline when 
attached, then either configuration could be effectively 
argued since the phenanthroline would be close to the CCA 3*- 
terminus of the tRNA*"**® and the 23S rRNA concurrently and would 
allow cleavage of nucleotide 2394 in either conformation. If 
the maximum distance for cleavage of the rRNA by the 
phenanthroline molecule is taken to be 15-20Â, then there 
would be a greater chance of cleavage of the 23S rRNA when the 
tRNA was in the R-configuration. However, this is just 
speculation since the exact location of the phenanthroline 
molecule when covalently attached to the tRNA is not known.
Future direction of this technique should first include 
physical studies on the structure of the tRNA-phenanthroline 
molecule for better interpretation of results. More extensive 
binding and kinetic data would also be valuable to determine 
competition effects, and show integrity. Primer extension 
analysis of the entire rRNA molecule under investigation 
should be undertaken to thouroughly investigate any cleavage 
sites which may occur below the level of detection of 
methylene blue dye. Primer extension would yield more 
information as to the interactions between the tRNA molecule 
and the ribosome. Finally, by placing the phenanthroline 
molecule at different positions on the tRNA and binding the
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tRNA-phenanthrol ine complex to specific sites on the ribosome, 
the position of the entire tRNA molecule when bound to all the
binding sites could be mapped.
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Figure 16. Most probable orientation of the phenanthroline 
group in the tRNA-OP molecule.
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